ArticleFrontiers in endocrinology2025
Association between the triglyceride-glucose index and hyperuricemia: potential role of obesity in patients with Type 2 diabetes mellitus.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prevalence and risk factors of hyperuricemia and gout in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.Frontiers in endocrinology · 2026Pooled it
- Association Between TyG-WC and Gout in American Adults: A Cross-Sectional Study of NHANES 2003-2018.Health science reports · 2026Article
- Nonlinear Association of the Triglyceride-Glucose Index With Hyperuricemia Among Young Chinese Adults.Journal of clinical hypertension (Greenwich, Conn.) · 2026Article
- Association between the Zhejiang University index and hyperuricemia among adults with type 2 diabetes in China.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The triglyceride-glucose (TyG) index has recently emerged as a simple surrogate marker of insulin resistance. However, the relationships among the TyG index, obesity, and hyperuricemia in individuals with T2DM remain unclear. This study investigates the associations of the TyG index and obesity with hyperuricemia in T2DM, and the possible role of obesity in these associations. Methods: In this cross-sectional study, 1,159 adults with T2DM were enrolled. The TyG index was calculated as ln [fasting triglyceride (mg/dl) × fasting plasma glucose (mg/dl)/2]. Participants were stratified into hyperuricemia and non-hyperuricemia groups based on serum uric acid levels. Multivariable logistic regression and subgroup analyses were performed to assess the association between the TyG index and hyperuricemia. Mediation analysis quantified BMI's contribution to this relationship. Results: The prevalence of hyperuricemia was 30.7%. After adjustment for age, gender, HbA1c, diabetes duration, eGFR, HDL-C, LDL-C, hypertension, hyperlipidemia, coronary heart disease, smoking status, and alcohol consumption, each unit increase in the TyG index was independently associated with a 36% elevated risk of hyperuricemia (OR = 1.36, 95% CI: 1.10-1.68). Subgroup analyses showed consistent associations across different patient subgroups. Mediation analysis indicated that BMI accounted for 20.0% of the relationship. Conclusions: The TyG index and BMI were both associated with hyperuricemia in Chinese patients with T2DM, with BMI potentially representing an indirect link.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.